Literature DB >> 26824291

The factor VIII protein and its function.

Anna Mazurkiewicz-Pisarek1, Grażyna Płucienniczak1, Tomasz Ciach2, Andrzej Płucienniczak1.   

Abstract

Factor VIII (FVIII), an essential blood coagulation protein, is a key component of the fluid phase blood coagulation system. Human factor VIII is a single chain of about 300 kDa consisting of domains described as A1-A2-B-A3-C1-C2. The protein undergoes processing prior to secretion into blood resulting in a heavy chain of 200 kDa (A1-A2-B) and a light chain of 80 kDa (A3-C1-C2) linked by metal ions. The role of factor VIII is to increase the catalytic efficiency of factor IXa in the activation of factor X. Variants of these factors lead frequently also to severe bleeding disorders.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26824291     DOI: 10.18388/abp.2015_1056

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN: 0001-527X            Impact factor:   2.149


  10 in total

1.  Investigating Optimal Autologous Cellular Platforms for Prenatal or Perinatal Factor VIII Delivery to Treat Hemophilia A.

Authors:  Christopher Stem; Christopher Rodman; Ritu M Ramamurthy; Sunil George; Diane Meares; Andrew Farland; Anthony Atala; Christopher B Doering; H Trent Spencer; Christopher D Porada; Graça Almeida-Porada
Journal:  Front Cell Dev Biol       Date:  2021-08-10

2.  Pharmacokinetic variability of factor VIII concentrates in Chinese pediatric patients with moderate or severe hemophilia A.

Authors:  Zhenping Chen; Kun Huang; Gang Li; Yingzi Zhen; Xinyi Wu; Ai Di; Guoqing Liu; Zekun Li; Iorio Alfonso; Runhui Wu
Journal:  Pediatr Investig       Date:  2021-03-22

3.  Recombinant Factor VIII Measurement in a Hemophilia A Patient Undergoing Cardiopulmonary Bypass-Supported Cardiac Surgery.

Authors:  Jennifer Bezaire; Dorothy Thomson; Erick McNair
Journal:  J Extra Corpor Technol       Date:  2018-09

4.  [Optimized AAV package and experimental application of recombinant AAV8/hFⅧ for gene therapy on hemophilia A mice].

Authors:  J H Mao; Y Shen; Q Wang; Y Wang; Z Ruan; X D Xi
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-01-14

5.  Identification of Key Coagulation Activity Determining Elements in Canine Factor VIII.

Authors:  Jenni Firrman; Qizhao Wang; Wenman Wu; Biao Dong; Wenjing Cao; Andrea Rossi Moore; Sean Roberts; Barbara A Konkle; Carol Miao; LinShu Liu; Dong Li; Weidong Xiao
Journal:  Mol Ther Methods Clin Dev       Date:  2020-01-15       Impact factor: 6.698

6.  A SINE Insertion in F8 Gene Leads to Severe Form of Hemophilia A in a Family of Rhodesian Ridgebacks.

Authors:  Alexandra Kehl; Anita Haug Haaland; Ines Langbein-Detsch; Elisabeth Mueller
Journal:  Genes (Basel)       Date:  2021-01-21       Impact factor: 4.096

7.  Gender-specific differences in haemostatic parameters and their influence on blood loss in bimaxillary surgery.

Authors:  Michael Schwaiger; Sarah-Jayne Edmondson; Jasmin Rabensteiner; Florian Prüller; Thomas Gary; Wolfgang Zemann; Jürgen Wallner
Journal:  Clin Oral Investig       Date:  2022-01-11       Impact factor: 3.573

Review 8.  The Vascular Endothelium and Coagulation: Homeostasis, Disease, and Treatment, with a Focus on the Von Willebrand Factor and Factors VIII and V.

Authors:  Juan A De Pablo-Moreno; Luis Javier Serrano; Luis Revuelta; María José Sánchez; Antonio Liras
Journal:  Int J Mol Sci       Date:  2022-07-27       Impact factor: 6.208

9.  Evaluation of the activity levels of rat FVIII and human FVIII delivered by adeno-associated viral vectors both in vitro and in vivo.

Authors:  Wei Zhang; Jianhua Mao; Yan Shen; Guowei Zhang; Yanyan Shao; Zheng Ruan; Yun Wang; Wenman Wu; Xuefeng Wang; Jiang Zhu; Saijuan Chen; Weidong Xiao; Xiaodong Xi
Journal:  Blood Cells Mol Dis       Date:  2018-09-20       Impact factor: 3.039

Review 10.  Furin Protease: From SARS CoV-2 to Anthrax, Diabetes, and Hypertension.

Authors:  Kara Fitzgerald
Journal:  Perm J       Date:  2020
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.